Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Arne M. van Heusden"'
Autor:
Tjitske Zaat, Jan Peter P. De Bruin, Eva Groenewoud, Esther B. Baart, Wilhelmina Van Baal, Monique Brandes, Astrid E.P. Cantineau, Frank Broekmans, Susanne Gielen, Mariette Goddijn, Jeroen Van Disseldorp, Arne M. van Heusden, Eugenie M. Kaaijk, Nicole Klijn, Carolien A.M. Koks, Cornelia De Koning, Paul J.Q. Van Der Linden, Petra Manger, Lobke Moolenaar, Robbert Van Oppenraaij, Quirine Pieterse, Jesper M.J. Smeenk, Jantien Visser, Madelon Van Wely, Femke Mol
Publikováno v:
Fertility and Sterility. 118:e3-e4
Autor:
Janet Kwee, G.J. Scheffer, Frank J. M. Broekmans, Carolien A.M. Koks, Annemiek W. Nap, Jenneke C. Kasius, Ramon H. M. Dykgraaf, Eugenie M. Kaaijk, Jaap Friederich, Benedictus C. Schoot, Annemieke Hoek, Femke Mol, Corry H. de Koning, Kathrin Fleischer, Helen L. Torrance, Arne M. van Heusden, Leonie A. Louwe, Ronald J T van Golde, Walter K. H. Kuchenbecker, Ineke C. A. H. Janssen, Alexander V. Sluijmer, Marinus J.C. Eijkemans, Janine G. Smit, Marcel H.A van Hooff, Ben W.J. Mol, Petra A. P. Manger, Denise A. M. Perquin
Publikováno v:
Lancet (UK), 387(10038), 2622-2629. Elsevier Ltd.
The Lancet (London), 387, 2622-9
Lancet, 387(10038), 2622-2629. Elsevier Science
The Lancet, 387(10038), 2622. Elsevier Limited
Obstetrical & Gynecological Survey, 71(10), 600. Lippincott Williams and Wilkins
The Lancet, 387(10038), 2622-2629. ELSEVIER SCIENCE INC
Lancet, 387(10038), 2622-2629
The Lancet (London), 387, 10038, pp. 2622-9
Lancet, 387(10038), 2622-2629. Elsevier Limited
The Lancet (London), 387, 2622-9
Lancet, 387(10038), 2622-2629. Elsevier Science
The Lancet, 387(10038), 2622. Elsevier Limited
Obstetrical & Gynecological Survey, 71(10), 600. Lippincott Williams and Wilkins
The Lancet, 387(10038), 2622-2629. ELSEVIER SCIENCE INC
Lancet, 387(10038), 2622-2629
The Lancet (London), 387, 10038, pp. 2622-9
Lancet, 387(10038), 2622-2629. Elsevier Limited
Since the first successful live birth after in vitro fertilization (IVF) was reported in 1978, more than 5 million children have been born with the help of this and intracytoplasmic sperm injection (ICSI) procedures. However, only approximately 25% t
Publikováno v:
Journal of Assisted Reproduction and Genetics. 15:18-21
Purpose: The chance of recurrence of poor fertilization in a second in vitro fertilization (IVF) cycle was assessed. Methods: Total fertilization failure was defined, and the relationship between the fertilization rate and the number of motile sperm
Publikováno v:
Endocrine Reviews. 18:71-106
I. Introduction II. Dynamics of Normal Human Follicle Growth and Selection A. Gonadotropin-independent and -dependent follicle growth B. Intrafollicular endocrine changes C. Are estrogens needed for follicle development? D. In vivo regulation of foll
Publikováno v:
Fertility and Sterility. 66:969-973
Objective To determine whether age or response to controlled ovarian hyperstimulation (COH) is a better predictor of IVF outcome in women≥40years. Design Retrospective analysis. Setting A transport IVF program. Patient(s) For patients undergoing IV
Autor:
Frank J.M. Broekmans, Arie Verhoeff, Egbert A. Brinkhuis, Petra A. P. Manger, Gabrielle J. Scheffer, Harold R. Verhoeve, Janet Kwee, Alexander V. Sluijmer, Ron J. T. van Golde, Annemieke Hoek, Annemiek W. Nap, Carolien A.M. Koks, Fulco van der Veen, Cornelis B. Lambalk, Marinus J.C. Eijkemans, Jaap Friederich, F.M. Helmerhorst, Kathrin Fleischer, Ben W.J. Mol, Jesper M. J. Smeenk, Arne M. van Heusden, Theodora C. van Tilborg, Walter K. H. Kuchenbecker, Jan Bruin, Joop S.E. Laven, Helen L. Torrance, Marcel H.A van Hooff
Publikováno v:
BMC Womens Health, 12:29. BioMed Central Ltd.
BMC Women's Health, 12
BMC Women's Health, 12:29. BioMed Central
BMC Women's Health
BMC Women's health, 12(1). BioMed Central
BMC Women's Health, 12, pp. 29-29
BMC Womens Health, 12. BioMed Central Ltd.
BMC Women's Health, 12, 29-29
van Tilborg, T C, Eijkemans, M J C, Laven, J S E, Koks, C A, de Bruin, J P, Scheffer, G J, van Golde, R J, Fleischer, K, Hoek, A, Nap, A W, Kuchenbecker, W K, Manger, P A, Brinkhuis, E A, van Heusden, A M, Sluijmer, A V, Verhoeff, A, van Hooff, M H, Friederich, J, Smeenk, J M, Kwee, J, Verhoeve, H R, Lambalk, C B, Helmerhorst, F M, van der Veen, F, Mol, B W J, Torrance, H L & Broekmans, F J 2012, ' The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial ', BMC Women's Health, vol. 12, 29, pp. 29 . https://doi.org/10.1186/1472-6874-12-29
BMC Women's Health, Vol 12, Iss 1, p 29 (2012)
BMC Women's Health, 12
BMC Women's Health, 12:29. BioMed Central
BMC Women's Health
BMC Women's health, 12(1). BioMed Central
BMC Women's Health, 12, pp. 29-29
BMC Womens Health, 12. BioMed Central Ltd.
BMC Women's Health, 12, 29-29
van Tilborg, T C, Eijkemans, M J C, Laven, J S E, Koks, C A, de Bruin, J P, Scheffer, G J, van Golde, R J, Fleischer, K, Hoek, A, Nap, A W, Kuchenbecker, W K, Manger, P A, Brinkhuis, E A, van Heusden, A M, Sluijmer, A V, Verhoeff, A, van Hooff, M H, Friederich, J, Smeenk, J M, Kwee, J, Verhoeve, H R, Lambalk, C B, Helmerhorst, F M, van der Veen, F, Mol, B W J, Torrance, H L & Broekmans, F J 2012, ' The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial ', BMC Women's Health, vol. 12, 29, pp. 29 . https://doi.org/10.1186/1472-6874-12-29
BMC Women's Health, Vol 12, Iss 1, p 29 (2012)
Contains fulltext : 109739.pdf (Publisher’s version ) (Open Access) ABSTRACT: BACKGROUND: Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16cc4bc25d1098ef3fc30127fccd9231
https://research.rug.nl/en/publications/0ac3bca0-03e5-4410-b65a-c80c38a6e51f
https://research.rug.nl/en/publications/0ac3bca0-03e5-4410-b65a-c80c38a6e51f
Autor:
Dick B. C. Schoot, Ron J. T. van Golde, Helen L. Torrance, Arne M. van Heusden, Gabrielle J. Scheffer, Jurjen G. E. Oosterhuis, Annemieke Hoek, Jaap Friederich, Frank J.M. Broekmans, Carolien A.M. Koks, Alexander V. Sluijmer, Femke Mol, Petra A. P. Manger, Ben W.J. Mol, Kathrin Fleischer, Leonie A. Louwe, Janine G. Smit, Jantien J. Boomgaard, M. Kaplan, Ineke C. A. H. Janssen, Annemiek W. Nap, Marcel H A Van Hooff, Corry H. de Koning, Joop S.E. Laven, Denise A. M. Perquin, Eugenie M. Kaaijk, Janet Kwee, Walter K. H. Kuchenbecker, Marinus J.C. Eijkemans, Jenneke C. Kasius
Publikováno v:
BMC Womens Health, 12. BioMed Central Ltd.
BMC Women's health, 12(1). BioMed Central
BMC Womens Health, 12:22. BioMed Central Ltd.
BMC Women's Health, 12, pp. 22-22
BMC Women's Health
BMC Women's Health, Vol 12, Iss 1, p 22 (2012)
BMC Women's Health, 12
BMC Women's Health, 12, 22-22
BMC Women's health, 12(1). BioMed Central
BMC Womens Health, 12:22. BioMed Central Ltd.
BMC Women's Health, 12, pp. 22-22
BMC Women's Health
BMC Women's Health, Vol 12, Iss 1, p 22 (2012)
BMC Women's Health, 12
BMC Women's Health, 12, 22-22
Contains fulltext : 109856.pdf (Publisher’s version ) (Open Access) ABSTRACT: BACKGROUND: In in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of preg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7575466d8d891f0c7082fbe21be8f725
https://pure.eur.nl/en/publications/ec3da5af-bd4b-44e5-9078-1fed5c097498
https://pure.eur.nl/en/publications/ec3da5af-bd4b-44e5-9078-1fed5c097498
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 55:123-127
Objectives: To compare efficacy, acceptability and patient preference of a single oral dose of fluconazole with a single intravaginal dose of 500 mg clotrimazole (medication groups) in women with vaginal candidosis visiting gynaecologists or general
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 38:75-78
A case report is presented in which a triplet pregnancy ended in an immature delivery of triplet A at 20 weeks gestation, followed by a successful delay in delivery of 49 days of triplets B and C by means of a cervical cerclage and tocolysis. This is
Publikováno v:
Fertility & Sterility, 67(2), 290-295. Elsevier Inc.
Objective To investigate whether the incidence and obstetric outcome of triplet pregnancies after IVF treatment justify strict limitation of the number of embryos to be replaced to two. Design Retrospective analysis. Setting A transport IVF program.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5e2960e88ee8a6f99d9eb58eb9246d
https://pure.eur.nl/en/publications/4bc66175-6431-408e-9fcf-f3778c6161de
https://pure.eur.nl/en/publications/4bc66175-6431-408e-9fcf-f3778c6161de